Bridges Investment Management Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 156,618 shares of the healthcare conglomerate’s stock after selling 279 shares during the period. UnitedHealth Group makes up approximately 1.7% of Bridges Investment Management Inc.’s investment portfolio, making the stock its 17th biggest holding. Bridges Investment Management Inc.’s holdings in UnitedHealth Group were worth $58,273,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Accel Wealth Management purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. Atlas Private Wealth Advisors increased its stake in shares of UnitedHealth Group by 46.2% in the first quarter. Atlas Private Wealth Advisors now owns 95 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 30 shares during the period. Sage Private Wealth Group LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at $36,000. IronBridge Private Wealth LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $37,000. Finally, Costello Asset Management INC lifted its holdings in shares of UnitedHealth Group by 500.0% in the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after buying an additional 100 shares during the period. 86.03% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages have issued reports on UNH. Bank of America reissued a “buy” rating and issued a $415.00 price target on shares of UnitedHealth Group in a report on Thursday, January 21st. Truist increased their target price on UnitedHealth Group from $420.00 to $450.00 in a research report on Wednesday, April 14th. BMO Capital Markets increased their price objective on shares of UnitedHealth Group from $410.00 to $435.00 and gave the company a “market perform” rating in a report on Thursday, April 22nd. Barclays upped their price target on shares of UnitedHealth Group from $405.00 to $435.00 and gave the stock an “overweight” rating in a research report on Thursday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $409.00 to $418.00 and gave the stock a “buy” rating in a research note on Thursday, April 22nd. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $412.26.
Shares of UNH opened at $409.80 on Monday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The firm has a market cap of $386.73 billion, a P/E ratio of 23.54, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. The company’s 50-day moving average price is $389.73 and its 200 day moving average price is $353.97. UnitedHealth Group Incorporated has a 12-month low of $273.71 and a 12-month high of $425.98.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $4.38 by $0.93. The business had revenue of $70.20 billion during the quarter, compared to analyst estimates of $69.13 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter last year, the firm posted $3.72 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.22%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s payout ratio is currently 33.09%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
See Also: What is a stock portfolio tracker?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.